呼出气冷凝液在COPD、哮喘、肺癌及间质性肺疾病中应用的研究进展  

Advances of Application of Exhaled Breath Condensate in COPD, Asthma, Lung Cancer and Interstitial Lung Disease

作　　者：杨伟煌[1] 黄平[1] 

机构地区：[1]广东医学院附属深圳南山医院,广东深圳518052

出　　处：《中国医学创新》2015年第10期153-156,共4页Medical Innovation of China

摘　　要：呼出气冷凝液(EBC)是一种新兴的呼吸道系统疾病检测方法。通过检测EBC中的实时生物标记物,以评价气道急慢性炎症、氧化应激水平。由于EBC具有无创、实时监测、简便、可重复等优点,具有良好的发展应用前景,因而可作为肺部疾病的诊断、疾病严重程度、药物疗效及预后评估,在COPD、哮喘、肺癌及间质性肺病得到广泛应用。本文对近年来EBC在COPD、哮喘、肺癌及间质性肺病中的研究做简要综述。Exhaled breath condensate（ EBC） is a new method for the detection of respiratory system diseases. Detecting real-time biomarkers in EBC evaluates acute and chronic airway inflammation and oxidative stress level.Since the EBC has non-invasive, real-time monitoring, simple, repeatable advantages, it can be used as diagnosis of lung disease, severity assessment, evaluation of drug efficacy and prognostic marker,and has good application prospects. EBC has extensive application in COPD, asthma, lung cancer and interstitial lung disease.In this paper, we review the advances of EBC in COPD, asthma, lung cancer and interstitial lung disease.

关 键 词：呼出气冷凝液 哮喘 肺癌 间质性肺病 

分 类 号：R56[医药卫生—呼吸系统] R734.2[医药卫生—内科学]